Medical - Diagnostics & Research stocks
Every US Medical - Diagnostics & Research company with filed annual reports: 51, in the Healthcare sector, with the ratios the screener prints. A name opens the company’s page, where every filed figure carries the filing it was read from and every price the day of its close.
Medians across Medical - Diagnostics & Research companies
- Price to earnings
- 39.19x of 17
- Price to book
- 3.16x of 38
- Enterprise value to EBIT
- 35.01x of 15
- Free cash flow yield
- 0.3% of 39
- Return on invested capital, after tax
- 5.9% of 19
- Debt to equity
- 0.43 of 28
- Dividend yield
- 0.6% of 6
The companies
| Company | Market cap | P/E | P/B | EV/EBIT | FCF yld | ROIC | D/E | Div yld |
|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. TMO | 257.50B | 39.19x | 4.93x | 38.02x | 2.4% | 8.5% | 0.77 | 0.3% |
| Danaher Corporation DHR | 162.70B | 45.66x | 3.16x | 38.56x | 3.2% | 5.9% | 0.37 | 0.7% |
| Natera, Inc. NTRA | 58.35B | n/m | 32.32x | n/a | 0.2% | n/a | n/a | n/a |
| Agilent Technologies, Inc. A | 49.50B | 38.25x | 7.42x | 35.01x | 2.3% | 15.8% | 0.53 | 0.6% |
| IQVIA Holdings Inc. IQV | 44.61B | 34.27x | 7.23x | 28.10x | 4.4% | 8.8% | 2.50 | n/a |
| Waters Corporation WAT | 43.61B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| IDEXX Laboratories, Inc. IDXX | 43.11B | 41.55x | 27.62x | 32.89x | 2.4% | 54.3% | 0.36 | n/a |
| Illumina, Inc. ILMN | 40.46B | 48.98x | 15.35x | n/a | 2.2% | n/a | n/a | n/a |
| Mettler-Toledo International Inc. MTD | 32.84B | 38.87x | n/m | 32.30x | 2.5% | 42.3% | n/m | n/a |
| Quest Diagnostics Incorporated DGX | 26.38B | 26.95x | 3.77x | 21.20x | 5.0% | 9.0% | 0.89 | 1.4% |
| Labcorp Holdings Inc. LH | 26.36B | 30.84x | 3.16x | 24.00x | 4.4% | n/a | 0.76 | 0.9% |
| Guardant Health, Inc. GH | 22.26B | n/m | n/m | n/a | -1.1% | n/a | n/m | n/a |
| Medpace Holdings, Inc. MEDP | 17.55B | 40.19x | 40.43x | 34.02x | 3.7% | 450.0% | 0.30 | n/a |
| Revvity, Inc. RVTY | 17.26B | 74.74x | 2.49x | 57.44x | 2.8% | 3.3% | 0.46 | 0.2% |
| Charles River Laboratories International, Inc. CRL | 14.75B | n/m | 4.80x | 700.29x | 3.4% | n/a | 0.84 | n/a |
| ICON Public Limited Company ICLR | 13.51B | 58.92x | 1.47x | 37.08x | 6.4% | 3.3% | 0.39 | n/a |
| Qiagen N.V. QGEN | 9.51B | 22.39x | 2.52x | 22.51x | 4.8% | 8.5% | 0.48 | n/a |
| Twist Bioscience Corporation TWST | 9.51B | n/m | 18.27x | n/a | -0.9% | n/a | n/a | n/a |
| GRAIL, Inc. GRAL | 6.05B | n/m | 1.93x | n/a | -6.0% | -18.0% | 0.02 | n/a |
| RadNet, Inc. RDNT | 5.54B | n/m | 4.86x | 103.01x | 1.6% | 1.5% | 1.71 | n/a |
| Sotera Health Company SHC | 5.15B | 66.93x | 8.54x | n/a | 2.9% | n/a | 3.75 | n/a |
| BillionToOne, Inc. BLLN | 4.85B | 570.72x | 10.10x | 278.38x | 0.3% | 16.6% | 0.23 | n/a |
| CareDx, Inc CDNA | 3.45B | n/m | 11.72x | n/a | n/a | n/a | n/a | n/a |
| Neogen Corporation NEOG | 2.68B | n/m | 1.28x | n/a | 1.2% | -0.7% | 0.39 | n/a |
| NeoGenomics, Inc. NEO | 2.25B | n/m | 2.64x | n/a | -1.0% | -10.4% | 0.49 | n/a |
| Personalis, Inc. PSNL | 1.70B | n/m | 5.44x | n/a | -5.6% | n/a | n/a | n/a |
| OPKO Health, Inc. OPK | 1.20B | n/m | 0.95x | n/a | -15.8% | -11.4% | 0.04 | n/a |
| Castle Biosciences, Inc. CSTL | 1.03B | n/m | 2.08x | n/a | 2.9% | n/a | 0.08 | n/a |
| Fulgent Genetics, Inc. FLGT | 587.2M | n/m | 0.59x | n/a | -18.9% | n/a | n/a | n/a |
| Aclaris Therapeutics, Inc. ACRS | 513.0M | n/m | 4.15x | n/a | -11.0% | n/a | n/a | n/a |
| Myriad Genetics, Inc. MYGN | 416.1M | n/m | 1.09x | n/a | n/a | n/a | n/a | n/a |
| Prenetics Global Limited PRE | 347.3M | n/m | 2.04x | n/a | -8.6% | n/a | n/a | n/a |
| Exagen Inc. XGN | 207.4M | n/m | 10.58x | n/a | -7.7% | n/a | 1.59 | n/a |
| Biodesix, Inc. BDSX | 201.1M | n/m | n/m | n/a | -12.6% | n/a | n/m | n/a |
| Trinity Biotech plc TRIB | 160.6M | n/m | n/m | n/a | -2.9% | n/a | n/m | n/a |
| Neuronetics, Inc. STIM | 148.6M | n/m | 5.75x | n/a | -16.5% | n/a | 4.04 | n/a |
| Sera Prognostics, Inc. SERA | 78.1M | n/m | 1.28x | n/a | -27.2% | -49.5% | 0.03 | n/a |
| MDxHealth S.A. MDXH | 57.6M | n/m | n/m | n/a | -5.8% | n/a | n/m | n/a |
| DarioHealth Corp. DRIO | 50.3M | n/a | n/a | n/a | n/a | n/a | 0.47 | n/a |
| Precipio, Inc. PRPO | 40.4M | n/m | 2.48x | n/a | 1.0% | -7.7% | 0.25 | n/a |
| Star Equity Holdings, Inc. STRR | 36.9M | n/m | 0.49x | n/a | -28.0% | n/a | 0.40 | n/a |
| bioAffinity Technologies, Inc. BIAF | 24.9M | n/m | n/a | n/a | n/m | n/a | 0.16 | n/a |
| Burning Rock Biotech Limited BNR | 16.4M | n/m | 0.21x | n/a | -30.6% | n/a | n/a | n/a |
| Bionano Genomics, Inc. BNGO | 16.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Advanced Biomed Inc. Common Stock ADVB | 8.1M | 0.92x | 0.50x | n/a | n/a | n/a | n/a | n/a |
| ENDRA Life Sciences Inc. NDRA | 7.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Intelligent Bio Solutions Inc. INBS | 4.8M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Check-Cap Ltd. Ordinary Share MBAI | 3.1M | 0.75x | 0.90x | n/a | n/a | n/a | n/a | n/a |
| BioNexus Gene Lab Corp. BGLC | 3.0M | n/m | 0.34x | n/a | -63.5% | n/a | n/a | n/a |
| iSpecimen Inc. ISPC | 2.6M | n/m | n/a | n/a | n/m | n/m | 0.09 | n/a |
| VolitionRx Limited VNRX | 2.3M | n/m | n/m | n/a | n/m | n/m | n/m | n/a |
Largest published market value first. No ratio orders this list, and a company whose market value is not published is listed last.
Prices as of 2026-10-15. Ratios recomputed from the filings 2026-10-15. Every ratio passes the same applicability gate as the screener and the research page, with the latest filed fiscal year's statements. A list is not a recommendation: see the limits of what this tool can tell you.